摘要(英) |
SOCS-3 (suppressors of cytokine signaling-3) is a 24.7 kDa protein that plays a very important role in the signaling transduction of insulin resistance caused by resistin in 3T3-L1 adipocytes. However, we found that cycloheximide, a protein synthesis inhibitor, could stimulate SOCS-3 mRNA expression in 3T3-L1 adipocytes. Despite of these, the exact mechanism of cycloheximide’s action on SOCS-3 gene expression and its effect on adipocyte are still unknown. Therefore, this study was to investigate how cycloheximide could affect the expression of adipocyte SOCS-3 gene. We found that cycloheximide stimulated SOCS-3 mRNA expression in a time- and dose-dependent manner. Actinomycin-D (a transcription inhibitor) blocked the cycloheximide-stimulated SOCS-3 mRNA expression, suggesting the need of a new mRNA synthesis, but not due to changes in the mRNA stability. Interestingly, cycloheximide did not significantly alter the SOCS-3 protein levels. Pretreatment with U0126 (an ERK MAPK inhibitor) reduced the cycloheximide-stimulated SOCS-3 mRNA levels by 50%. This suggests the ERK-dependent effect of cycloheximide. Treatment with an additional protein inhibitor, such as anisomycin, also stimulated SOCS-3 mRNA expression in C3H10T1/2 adipocyte and C2C12 myoblast, but it had no effect on H4IIEC3 hepatoma cell. This suggests that the cycloheximide effects vary with the cell types. Moreover, cycloheximide stimulated gene expression of other SOCS family members, such as SOCS-1,SOCS-2,SOCS-4,SOCS-5,SOCS-6,SOCS-7 and CIS;However, the different peak time of the individual SOCS mRNA level occurred among SOCSs. Finally, we found that the dose of cycloheximide at 10 μg/ml for 6-24 h and 5 μg/ml for 12-24 h, but not 5 μg/ml within 6 h, reduced cell number and cell viability of the preadipocytes and adipocytes. We conclude that cycloheximide stimulates 3T3-L1 adipocyte SOCS-3 mRNA expression via the MEK1/ERK-dependent pathway. Further study is needed to demonstrate whether the effects of cycloheximide on SOCS-3 gene expression are related to its action on fat cell viability.
|
參考文獻 |
1. Leach BE, Ford JH, and Whiffen AJ (1947) Actidione, an antibiotic from Streptomyces griseus. J Am Chem Soc 69(2):474.
2. Whiffen AJ, Bohonos N, and Emerson RL (1946) The Production of an Antifungal Antibiotic by Streptomyces griseus. J Bacteriol 52(5):610-611.
3. Kerridge D (1958) The effect of actidione and other antifungal agents on nucleic acid and protein synthesis in Saccharomyces carlsbergensis. J Gen Microbiol 19(3):497-506.
4. Siegel MR and Sisler HD (1963) Inhibition of Protein Synthesis in Vitro by Cycloheximide. Nature 200:675-676.
5. Baliga BS, Pronczuk AW, and Munro HN (1969) Mechanism of cycloheximide inhibition of protein synthesis in a cell-free system prepared from rat liver. J Biol Chem 244(16):4480-4489.
6. Grollman AP (1966) Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics. Proc Natl Acad Sci U S A 56(6):1867-1874.
7. Mahadevan LC and Edwards DR (1991) Signalling and superinduction. Nature 349(6312):747-748.
8. Zinck R, et al. (1995) Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 15(9):4930-4938.
9. Kyriakis JM, et al. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369(6476):156-160.
10. Alessenko AV, et al. (1997) Mechanisms of cycloheximide-induced apoptosis in liver cells. FEBS Lett 416(1):113-116.
11. Ito K, et al. (2006) Molecular mechanism investigation of cycloheximide-induced hepatocyte apoptosis in rat livers by morphological and microarray analysis. Toxicology 219(1-3):175-186.
12. Sutter RP and Moldave K (1966) The interaction of aminoacyl transferase II and ribosomes. J Biol Chem 241(8):1698-1704.
13. Dennis VA, Jefferson A, Singh SR, Ganapamo F, and Philipp MT (2006) Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3. Infect Immun 74(10):5780-5789.
14. Bruun C, et al. (2009) Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells. Mol Cell Endocrinol 311(1-2):32-38.
15. Kuo PL, Ni WC, Tsai EM, and Hsu YL (2009) Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells. Molecular Cancer Therapeutics 8(5):1328-1339.
16. Larsen L and Ropke C (2002) Suppressors of cytokine signalling: SOCS. APMIS 110(12):833-844.
17. Croker BA, Kiu H, and Nicholson SE (2008) SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 19(4):414-422.
18. Palmer DC and Restifo NP (2009) Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 30(12):592-602.
19. Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, and Lazar MA (2005) Activation of SOCS-3 by resistin. Mol Cell Biol 25(4):1569-1575.
20. Marine JC, et al. (1999) SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98(5):617-627.
21. Sasaki A, et al. (2000) CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 275(38):29338-29347.
22. Rui L, Yuan M, Frantz D, Shoelson S, and White MF (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277(44):42394-42398.
23. Hilton DJ, et al. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A 95(1):114-119.
24. Croker BA, et al. (2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20(2):153-165.
25. Croker BA, et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4(6):540-545.
26. Lang R, et al. (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 4(6):546-550.
27. Weber A, et al. (2005) SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24(44):6699-6708.
28. Seki Y, et al. (2002) Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A 99(20):13003-13008.
29. Kario E, et al. (2005) Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. J Biol Chem 280(8):7038-7048.
30. Krebs DL, et al. (2002) SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol Cell Biol 22(13):4567-4578.
31. Banks AS, et al. (2005) Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J Clin Invest 115(9):2462-2471.
32. Metcalf D, et al. (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405(6790):1069-1073.
33. He B, et al. (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. P Natl Acad Sci USA 100(24):14133-14138.
34. Baliga BS and Munro HN (1971) Specificity of mammalian transferase II binding to ribosomes. Nat New Biol 233(43):257-258.
35. Baliga BS, Nolan RD, and Munro HN (1971) The site and nature of transferase II-guanosine triphosphate complex attachment to mammalian ribosomes. Biochem J 124(5):51P.
36. Munro HN, Baliga BS, and Pronczuk AW (1968) In vitro inhibition of peptide synthesis and GTP hydrolysis by cycloheximide and reversal of inhibition by glutathione. Nature 219(5157):944-946.
37. Hsieh CF, et al. (2010) Green tea epigallocatechin gallate inhibits insulin stimulation of adipocyte glucose uptake via the 67-kilodalton laminin receptor and AMP-activated protein kinase pathways. Planta Med 76(15):1694-1698.
38. Hung PF, et al. (2005) Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways. Am J Physiol Cell Physiol 288(5):C1094-1108.
39. Ahmad N and Mukhtar H (1999) Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev 57(3):78-83.
40. Emanuelli B, et al. (2000) SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem.
41. Wang Z, et al. (2000) Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophys Res Commun 277(1):20-26.
42. Fasshauer M, et al. (2004) Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes. J Endocrinol 181(1):129-138.
43. Charlotte L and Hakan B (2001) PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. Endocrinology 142(11):4880–4890.
|